Skip to main content
OTCMKTS:SEOVF

Sernova Stock Forecast, Price & News

$1.09
-0.03 (-2.68 %)
(As of 05/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.09
$1.12
50-Day Range
$1.08
$1.27
52-Week Range
$0.11
$2.23
Volume39,814 shs
Average Volume128,500 shs
Market Capitalization$281.60 million
P/E RatioN/A
Dividend YieldN/A
Beta1.46
30 days | 90 days | 365 days | Advanced Chart
Receive SEOVF News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.


Sernova logo

About Sernova

Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SEOVF
CUSIPN/A
CIKN/A
Phone519-858-5184
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A
Book Value$0.02 per share

Profitability

Net Income$-2,990,000.00

Debt

Price-To-Earnings

Miscellaneous

Market Cap$281.60 million
Next Earnings Date6/24/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.54 out of 5 stars

Medical Sector

1509th out of 2,038 stocks

Pharmaceutical Preparations Industry

631st out of 769 stocks

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Sernova (OTCMKTS:SEOVF) Frequently Asked Questions

What stocks does MarketBeat like better than Sernova?

Wall Street analysts have given Sernova a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sernova wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sernova?

Sernova saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,089,400 shares, an increase of 130.3% from the March 15th total of 473,100 shares. Based on an average daily volume of 113,600 shares, the short-interest ratio is currently 9.6 days.
View Sernova's Short Interest
.

When is Sernova's next earnings date?

Sernova is scheduled to release its next quarterly earnings announcement on Thursday, June 24th 2021.
View our earnings forecast for Sernova
.

How were Sernova's earnings last quarter?

Sernova Corp. (OTCMKTS:SEOVF) announced its quarterly earnings data on Thursday, March, 25th. The company reported ($0.01) earnings per share (EPS) for the quarter.
View Sernova's earnings history
.

How has Sernova's stock been impacted by Coronavirus?

Sernova's stock was trading at $0.1092 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SEOVF shares have increased by 899.1% and is now trading at $1.0910.
View which stocks have been most impacted by COVID-19
.

Who are Sernova's key executives?

Sernova's management team includes the following people:
  • Dr. Philip M. Toleikis, Pres, CEO & Director
  • Mr. David Swetlow C.A., CPA, C.A, Chief Financial Officer
  • Mr. Douglas Maret, Chief Science Officer

Who are some of Sernova's key competitors?

What is Sernova's stock symbol?

Sernova trades on the OTCMKTS under the ticker symbol "SEOVF."

How do I buy shares of Sernova?

Shares of SEOVF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sernova's stock price today?

One share of SEOVF stock can currently be purchased for approximately $1.09.

How much money does Sernova make?

Sernova has a market capitalization of $281.60 million.

What is Sernova's official website?

The official website for Sernova is www.sernova.com.

Where are Sernova's headquarters?

Sernova is headquartered at 700 COLLIP CIRCLE SUITE 114, LONDON A6, N6G 4X8.

How can I contact Sernova?

Sernova's mailing address is 700 COLLIP CIRCLE SUITE 114, LONDON A6, N6G 4X8. The company can be reached via phone at 519-858-5184 or via email at [email protected]


This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.